INNOVO® attends IUGA Conference, Vienna 2018
INNOVO®'s developer, Irish based company Atlantic Therapeutics Ltd, were proud to present the latest clinical research on INNOVO® at the 43rd Meeting of the International Urogynaecological Association (IUGA), taking place in Vienna, Austria this week.
The study, entitled “A Randomised, Controlled, Double-Blind, Clinical Study to Compare Two Neuromuscular Stimulator Devices In Female Stress Urinary Incontinence: Effects on Symptoms and Quality of Life”, demonstrates that INNOVO® is easy to use, and delivers a safe, effective, non-invasive treatment for stress urinary incontinence.
The research provides a great to support to current research which exists to support and prove the efficacy of INNOVO® as a long-term, non-invasive treatment for bladder weakness, in both women and men.
Recommended & Clinically Proven
93% of INNOVO® users saw significant improvement within 4 weeks. Start today!